TransEnterix, Inc. Gains 68.6%
Tue, Jan 19, 2021 at 05:30 PM
TransEnterix, Inc. (TRXC:NYSEMKT) rocketted at $3.49, representing a gain of 68.6%. On Fri 15 Jan 21, TRXC:NYSEMKT hit a New 2-Week High of $2.07. The stock got featured on our News Catalysts scanner on Tue 19 Jan 21 at 09:26 AM in the 'BIOTECH' category. From Mon 04 Jan 21, the stock recorded 55.56% Up Days and 60.00% Green Days
About TransEnterix, Inc. (TRXC:NYSEMKT)
TransEnterix Inc is a medical device company engaged in the development and commercialization of a robotic assisted surgical system called the SurgiBot System.
Top 10 Gainers:
- Gritstone Oncology, Inc. (GRTS:NASDAQ), 248.51%
- Aclaris Therapeutics, Inc. (ACRS:NASDAQ), 220.24%
- Inuvo, Inc. (INUV:NYSEMKT), 123.01%
- Senseonics Holdings, Inc. (SENS:NYSEMKT), 80.38%
- Gevo, Inc. (GEVO:NASDAQ), 72.34%
- TransEnterix, Inc. (TRXC:NYSEMKT), 68.6%
- ENDRA Life Sciences Inc. (NDRA:NASDAQ), 65.71%
- Dare Bioscience, Inc. (DARE:NASDAQ), 63.89%
- Motus GI Holdings, Inc. (MOTS:NASDAQ), 54.87%
- EHang Holdings Limited (EH:NASDAQ), 53.48%